Skip to content

Feasibility and acceptability of using a shared decision making intervention to support patient choice of airway clearance techniques in bronchiectasis physiotherapy consultations in the NHS

Feasibility and acceptability of using a Shared Decision Making intervention to support patient choice of Airway Clearance Techniques in bronchiectasis physiotherapy consultations in the NHS. The FAST-ACT Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN55381093
Enrollment
50
Registered
2025-12-10
Start date
2025-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis Respiratory

Interventions

The intervention is the provision of a Shared Decision Making (SDM) Patient Decision Aid. This was developed over the past 2 years as part of the wider PhD study. We conducted a qualitative study invo
1) the active cycle of breathing technique, 2) autogenic drainage and 3) an oscillating positive expiratory pressure device (for this study we will use the OPEP called “Aerobika”). Aerobika OPEP devic

Sponsors

Newcastle upon Tyne Hospitals NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. =18 years old 2. Radiological and clinical diagnosis of bronchiectasis 3. Capacity to consent and participate in SDM 4. Patient or their carer owns a mobile telephone 5. First visit to specialist bronchiectasis clinic

Exclusion criteria

Exclusion criteria: 1. Patients with cystic fibrosis (CF) bronchiectasis as aetiology

Design outcomes

Primary

MeasureTime frame
1. Feasibility of recruitment is measured using the proportion of patients approached who agree to undertake the study at baseline 2. Feasibility of retention is measured using the proportion of patients attending follow-up consultations at each follow-up timepoint 3. Feasibility of data collection is measured using completion rates of outcome data (e.g., questionnaires) at each data collection timepoint 4. Feasibility of intervention delivery is measured using the proportion of physiotherapy consultations in which the intervention is delivered within 30 minutes at each initial consultation 5. Health-related quality of life is measured using the Quality of Life-Bronchiectasis (QOL-B) questionnaire at baseline and each follow-up timepoint 6. Acceptability of shared decision-making is measured using the 9-item Shared Decision-Making Questionnaire (SDM-Q-9) for patients at the initial consultation and each follow-up consultation 7. Acceptability of shared decision-making is measured using the Shared Decision-Making Questionnaire for clinicians (SDM-Q-Doc) at the initial consultation 8. Fidelity to shared decision-making training is measured using OPTION 5 ratings of audio-recorded initial consultations selected by random sampling at baseline 9. Decisional conflict is measured using the Decisional Conflict Scale (DCS) for patients after the initial consultation only 10. Decision regret is measured using the Decision Regret Scale (DRS) for patients at each follow-up visit in relation to their initial chosen airway clearance technique

Secondary

MeasureTime frame
Adherence to ACTs measured with REDcap (https://projectredcap.org) via a mobile phone as a new reporting system for adherence to ACTs in bronchiectasis

Countries

England, United Kingdom

Contacts

Public ContactPaul McCallion
p.mccallion2@newcastle.ac.uk+44 191 2448218

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 3, 2026